We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

22 hedge funds and large institutions have $1.73M invested in Cocrystal Pharma in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0.09% more ownership

Funds ownership: 0.74% → 0.83% (+0.09%)

0% more funds holding

Funds holding: 22 → 22 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

70% less capital invested

Capital invested by funds: $5.71M → $1.73M (-$3.98M)

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
5
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$590K
2
WA
Wasatch Advisors
Utah
+$538K
3
Renaissance Technologies
Renaissance Technologies
New York
+$98.8K
4
Citadel Advisors
Citadel Advisors
Florida
+$29.5K
5
VF
Virtu Financial
New York
+$23.6K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$594K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$225K
3
Millennium Management
Millennium Management
New York
-$26K
4
Jane Street
Jane Street
New York
-$22K
5
Victory Capital Management
Victory Capital Management
Texas
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wasatch Advisors
Utah
$892K +$538K +53,897 +56%
Morgan Stanley
2
Morgan Stanley
New York
$353K +$590K +59,103 +20,241%
Vanguard Group
3
Vanguard Group
Pennsylvania
$179K – – –
EU
4
Emory University
Georgia
$76K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$64K +$98.8K +9,896 +1,128%
Bank of America
6
Bank of America
North Carolina
$53K -$1.68K -168 -2%
PA
7
Parallel Advisors
California
$24K +$529 +53 +1%
Citadel Advisors
8
Citadel Advisors
Florida
$18K +$29.5K +2,950 New
BlackRock
9
BlackRock
New York
$16K -$290 -29 -1%
VF
10
Virtu Financial
New York
$14K +$23.6K +2,362 New
SBH
11
Segall Bryant & Hamill
Illinois
$7K -$1.34K -134 -10%
BRWA
12
B. Riley Wealth Advisors
Florida
$7K – – –
Northern Trust
13
Northern Trust
Illinois
$7K – – –
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$6K – – –
SS
15
Sunbelt Securities
Texas
$6K – – –
Deutsche Bank
16
Deutsche Bank
Germany
$2K +$4.65K +466 New
NSIM
17
North Star Investment Management
Illinois
$1K – – –
Rockefeller Capital Management
18
Rockefeller Capital Management
New York
$1K – – –
PAM
19
Panagora Asset Management
Massachusetts
$1K +$300 +30 +53%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– -$594K -59,453 -100%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
– -$225K -9,182 Closed
Millennium Management
22
Millennium Management
New York
– -$26K -1,099 Closed
Jane Street
23
Jane Street
New York
– -$22K -898 Closed
Victory Capital Management
24
Victory Capital Management
Texas
– -$5K -196 Closed
CAPTRUST Financial Advisors
25
CAPTRUST Financial Advisors
North Carolina
– -$1K -56 Closed
1
2

COCP Hedge Fund Activity: Q4 2019 in Review

22 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q4 2019, worth a combined $1.73M — down 70% from $5.71M a quarter earlier.

Fund positioning in COCP was balanced in Q4 2019: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $590K. The largest seller was Royal Bank of Canada, cutting an estimated $594K.

  • 22 institutional investors held Cocrystal Pharma (COCP) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $1.73M of Cocrystal Pharma stock for Q4 2019, down 70% quarter-over-quarter.
  • 5 funds opened new Cocrystal Pharma positions in Q4 2019 and 5 closed out, a net change of 0 holders.
  • The largest Cocrystal Pharma buyer in Q4 2019 was Morgan Stanley, an estimated $590K added.
  • The largest Cocrystal Pharma seller in Q4 2019 was Royal Bank of Canada, an estimated $594K sold.

Based on aggregated 13F filings for Q4 2019.